张照杰,王 振,李向向,等.肿瘤相关中性粒细胞和PD-1/PD-L1在胃癌中研究进展[J].肿瘤学杂志,2026,32(2):112-118.
肿瘤相关中性粒细胞和PD-1/PD-L1在胃癌中研究进展
Reseach Progress of Tumor-Associated Neutrophils and PD-1/PD-L1 in Gastric Cancer
投稿时间:2025-03-29  
DOI:10.11735/j.issn.1671-170X.2026.02.B004
中文关键词:  胃肿瘤  肿瘤相关中性粒细胞  肿瘤微环境  PD-1  PD-L1
英文关键词:gastric neoplasms  tumor-associated neutrophils  tumor microenvironment  PD-1  PD-L1
基金项目:甘肃省卫生健康行业科研计划(GSWSKY2023-34);兰州市青年科技人才创新项目(2024-QN-39)
作者单位
张照杰 联勤保障部队第九四○医院 甘肃中医药大学第一临床医学院 
王 振 联勤保障部队第九四○医院 甘肃中医药大学第一临床医学院 
李向向 联勤保障部队第九四○医院 甘肃中医药大学第一临床医学院 
翟玉洁 联勤保障部队第九四○医院 甘肃中医药大学第一临床医学院 
摘要点击次数: 6
全文下载次数: 2
中文摘要:
      摘 要:胃癌具有较高的发病率及死亡率。近年来PD-1/PD-L1抑制剂因其高疗效及低副作用等特性成为研究热点,并且随着对肿瘤微环境的深入研究,发现肿瘤相关中性粒细胞(tumor-associated neutrophils,TANs)能影响PD-1/PD-L1在胃癌中的治疗效果。全文分析TANs、PD-1/PD-L1与胃癌的关系及免疫治疗的进展,TANs影响PD-1/PD-L1在胃癌中的治疗及耐药的具体作用机制,以及 TANs与PD-1/PD-L1治疗胃癌的当前挑战。
英文摘要:
      Abstract: Gastric cancer has a high incidence and mortality. In recent years, programmed cell death protein 1 (PD-1)/programmed cell death ligand 1 (PD-L1) inhibitors have become a research hotspot due to their high therapeutic efficacy and low side effects. With the in-depth study of the tumor microenvironment, it has been found that tumor associated neutrophils (TANs) can affect the therapeutic efficacy of PD-1/PD-L1 in gastric cancer. This paper analyzes the relationship between TANs, PD-1/PD-L1 and gastric cancer, as well as the progress of immunotherapy, the specific mechanism by which TANs affect the treatment efficacy and drug resistance of PD-1/PD-L1 inhibitors in gastric cancer, and the current challenges in utilizing TANs and PD-1/PD-L1 for the treatment of gastric cancer.
在线阅读   查看全文  查看/发表评论  下载PDF阅读器